GPHN and Alzheimer disease: Our findings correlate to those reported in 6–7-month-old 2 × Tg mice (another double transgenic model of AD), showing a reduced level of GlyR expression in the nucleus accumbens (nAc) parallel to a reduction in the pre- and post-synaptic markers SV2 and gephyrin.